Page 4 - Biofire Diagnostics News Today

Syndromic Multiplex Diagnostic Market Analysis, Trends, Top Manufacturers, Share, Growth, Statistics, Opportunities & Forecast to 2028 | Abbott Laboratories, Akonni Biosystems, Inc., Applied BioCode, Inc, BioFire Diagnostics iCrowd Newswire Worldwide Syndromic Multiplex Diagnostic Market Analysis to 2027 is a specialized and in-depth study of the Syndromic Multiplex Diagnostic Market Industry with a focus on the global market trend. The report aims to provide an overview of global Syndromic ...

To embed, copy and paste the code into your website or blog: Our Health Care Group explains how emergency use authorizations (EUAs) have been issued during the current public health emergency and the benefits and limitations of offering a test pursuant to an EUA and provides practical advice for test developers preparing for the end of the public emergency. When does an EUA declaration terminate? EUAs for diagnostics to detect SARS-CoV-2 What happens when the EUA declaration expires? Since the ...

COVID-19 Detection Test Kits And Consumables Global Market Report 2021: COVID-19 Implications And Growth To 2030 The Business Research Company’s COVID-19 Detection Test Kits and Consumables Global Market Report 2021: COVID-19 Implications And Growth To 2030 LONDON, GREATER LONDON, UK, May 12, 2021 /EINPresswire.com/ -- The escalating demand for cost-effective and quick COVID-19 detection kits coupled with the easing of regulatory processes for COVID-19 detection kits contributed to the growth...

Share this article Share this article ResearchAndMarkets.coms offering. This first edition report At-Home Testing: COVID-19 Trends and Future Potential provides an overview of trends and developments in the home testing industry for the pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This report covers trends that have occurred since the pandemic was declared in 2020 to the recent present - March 31, 2021. For the purp...

New testing technology can accurately distinguish between a viral and a bacterial infection for respiratory illness, according to a new study proving feasibility. The critical difference determines whether antibiotics are warranted. And, importantly, the test may provide results in under an hour. When patients complain of coughing, runny nose, sneezing, and fever, doctors are often stumped because they have no fundamental tool to identify the source of the respiratory symptoms and guide appropr...

New coronavirus saliva test gets emergency approval from FDA Doctors are often left in a fix when patients complain of symptoms that are common amongst infections(generally respiratory illnesses) caused by both bacteria and viruses. This is compounded by the absence of a rudimentary tool to identify the specific disease-cause pathogen. Offering such a diagnostic tool, scientists have developed a first-of-its-kind test that can accurately differentiate between bacterial and viral infections an...

New testing technology can accurately differentiate between viral and bacterial infections When patients complain of coughing, runny nose, sneezing and fever, doctors are often stumped because they have no fundamental tool to identify the source of the respiratory symptoms and guide appropriate treatments. That tool might finally be on its way. In a study proving feasibility, researchers at Duke Health showed that their testing technology can accurately distinguish between a viral and a bacteri...

Duke University Medical Center When patients complain of coughing, runny nose, sneezing and fever, doctors are often stumped because they have no fundamental tool to identify the source of the respiratory symptoms and guide appropriate treatments. That tool might finally be on its way. In a study proving feasibility, researchers at Duke Health showed that their testing technology can accurately distinguish between a viral and a bacterial infection for respiratory illness – a critical differen...

**    Duration of WHO-declared COVID-19 pandemic (a)  Wellcome Trust Publishers Pledge The first pandemic-related IP pledge addressed copyrights. On January 31, 2020, the Wellcome Trust, a large UK-based medical charity, led a group of approximately thirty scientific and medical publishers in committing to make all peer-reviewed research publications relating to COVID-19 available without charge on an open access basis. The signatories included Elsevier, Cell Press, Karger, the JAMA Network...

FDA authorizes marketing of first SARS-CoV-2 diagnostic test using De Novo premarket review pathway Today, the U.S. Food and Drug Administration granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), a diagnostic test for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of COVID-19 and other respiratory tract infections. The diagnostic test,...